| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.098 | 36.375 | 25.699 | 32.318 | 35.305 | 37.095 | 68.586 | 79.370 | 97.583 | 109.211 |
| Total Income - EUR | 33.098 | 36.375 | 25.699 | 34.794 | 35.305 | 39.972 | 69.080 | 79.370 | 97.583 | 109.625 |
| Total Expenses - EUR | 31.709 | 27.508 | 28.024 | 29.828 | 32.445 | 40.289 | 56.907 | 62.668 | 70.139 | 80.633 |
| Gross Profit/Loss - EUR | 1.389 | 8.867 | -2.325 | 4.966 | 2.859 | -317 | 12.173 | 16.701 | 27.443 | 28.992 |
| Net Profit/Loss - EUR | 397 | 8.503 | -2.582 | 4.618 | 2.506 | -685 | 11.496 | 16.027 | 26.614 | 25.868 |
| Employees | 4 | 4 | 0 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Flavi Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.300 | 6.960 | 5.415 | 5.650 | 5.686 | 4.329 | 32.820 | 30.609 | 33.522 | 27.959 |
| Current Assets | 651 | 2.169 | 1.313 | 938 | 1.013 | 1.566 | 3.396 | 14.360 | 20.636 | 24.581 |
| Inventories | 463 | 458 | 450 | 442 | 433 | 425 | 416 | 417 | 501 | 499 |
| Receivables | 169 | 168 | 165 | 162 | 159 | 191 | 173 | 224 | 224 | 762 |
| Cash | 19 | 1.544 | 698 | 335 | 421 | 950 | 2.807 | 13.719 | 19.911 | 23.320 |
| Shareholders Funds | 6.085 | 8.557 | 5.830 | 4.670 | 5.133 | 4.351 | 15.750 | 31.825 | 50.872 | 48.266 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.773 | 1.479 | 1.778 | 2.699 | 2.674 | 2.731 | 21.586 | 14.341 | 4.550 | 5.439 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Flavi Med Srl